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Abstract
Background: Renal impairment is a common complica-
tion of multiple myeloma occuring in up to 50 % of
patients at some stage in their disease. Due to occur-
rence of cast nephropathies we hypothesized circula-
tory  dysregulation  (vasoconstriction)  in  the  kidneys
with  measurable  elevation  of  the  resistance  index
among these patients which would have a diagnostic
impact.
Subjects and methods: 36 patients with treated multiple
myeloma (21 females, 15 males, mean age 61.6 ﾱ 8.5
years)  were  prospectively  examined  by  conventional
abdominal ultrasound with focussed investigation of
the kidneys. first, length of the organs, parenchymal
width and characterization of parenchymal echogenic-
ity were determined. then, intrarenal RI values were
measured in segmental and arcuate arteries, respective-
ly,  in  both  kidneys.  additionally,  serum  creatinine,
Bun and GfR of each patient were evaluated. RI val-
ues  were  compared  to  values  of  78  healthy  control
subjects.
Results: Mean  renal  RI  was  0.68  ﾱ  0.07  which  was
slightly higher than in controls with 0.62 ﾱ 0.05, but
without statistical significance. Due to the laboratory
analyses patients were subdivided in those with normal
( group 1, n = 21) and those with impaired (group 2, n
= 15) renal function. In both groups  kidney size and
parenchymal  width  were  normal.  significant  more
group 2 patients (60%) revealed hyperechogenic par  -
enchyma than group 1 patients (24%) (p<0.01).  Mean
renal RI indices were 0.67 ﾱ 0.06 (right) and 0.69 ﾱ
0.06 (left) in group 1 patients and 0.71 ﾱ 0.08 (right)
and 0.71 ﾱ 0.07 (left) in group 2 patients and showed
no significant difference (p = 0.06 and 0.15).
Conclusion: Renal RI values are not significantly elevat-
ed  in  patients  with  multiple  myeloma  even  in  those
with renal impairment so that no hints to a relevant
vasoconstriction could be evaluated. RI seems not to
be  a  relevant  parameter  for  the  diagnosis  of  cast
nephro  pathy of multiple myeloma patients. Routinely
performed ultrasound examination should be more fo-
cussed on the qualification of parenchymal echogenic-
ity.
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IntRoDuctIon
Renal impairment is a common complication of multi-
ple myeloma occuring in up to 50 % of patients at
some stage in their disease [1, 2]. Exceeded production
of monoclonal light chains by multiple myeloma cells
and their excretion in the urine as proteinuria (Bence
Jones proteins) is the main pathogenetic factor. later
on,  tubular  atrophy  and  interstitial  fibrosis  develops
with unfavourable prognosis and requirement of dialy-
sis in 2-3% of the patients [3-8]. the precipitation of
light chains, which form casts in the distal tubules, re-
sults in renal obstruction [9] and is the most common
cause of renal impairment in multiple myeloma. Due
to these parenchymal changes we hypothesized circu-
latory dysregulation in the kidneys with potential ele-
vation  of  the  resistance  index  (RI)  among  multiple
myeloma patients. Rivolta and coworkers showed that
renal RI correlates with the glomerular filtration rate
of the kidneys in patients with liver cirrhosis [10].
Measurement of the intrarenal resistance index has
been widely established in the evaluation of renovas-
cular  changes.  the  dopplersonographic  RI  measure-
ment is a wide-spread method to get indirect informa-
tion about the vessel resistance and the perfusion dis-
tal of the measuring point. 
the aim of our study was to perform renal RI mea-
surements in patients with multiple myeloma and to
evaluate  if  these  values  show  a  correlation  to  renal
function. Elevated renal RI values as hint to vasocon-
strictive effects in the kidneys of these patients would
have a diagnostic impact.
suBJEcts anD MEtHoDs
we prospectively examined 36 patients (21 females, 15
males, mean age 61.6 ﾱ 8.5 years) of our hematologi-
cal department with multiple myeloma who were sent
to  our  gastroenterological  department  for  a  routine
abdominal ultrasound investigation.
after  fasting  for  at  least  four  hours,  all  subjects
were  examined  by  B-mode  ultrasound  and  colour-
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vex scanner (siemens sonolInE Elegra, Erlangen,
Germany). Renal length and parenchymal width were
determined for both sides (fig.1). 
colour-flow-doppler signals were taken from seg-
mental arteries near hilum (seg) and arcuate arteries of
the cortex (arc) in the right and left kidney, respective-
ly. the examination was done from experienced inves-
tigators (us, HK, MG). Intrarenal RI was determined
from analysis of the spectral waveform as follows: the
peak systolic velocity minus the lowest diastolic veloci-
ty  divided  by  the  peak  systolic  velocity  (RI  =
[Vmaxsystole-VminDiastole]  /  Vmaxsystole).  the
height  of  the  pulsed  Doppler  waveform  was  maxi-
mized to facilitate measurement. the mean RI was cal-
culated  as  an  average  of  three  measurements.  Each
measurement was done on condition that at least three
waveforms followed each other (fig. 2). 
additionally, serum creatinine, blood urea nitrogen
(Bun)  and  GfR  of  each  patient  were  determined.
Glomerular filtration rate (GfR) was estimated by cal-
culated creatinine clearance.
Informed consent of the patients was given, respec-
tively.
RI values were compared with values of 78 healthy
control subjects.
statistical evaluation was performed by student’s t-
test. P-values < 0.05 were considered as statistical sig-
nificant. 
REsults
Mean renal RI was 0.68 ﾱ 0.07  which was somewhat
higher than in controls with 0.62 ﾱ 0.05, but without
statistical significance. 
Due to the laboratory analyses we subdivided the
patients in those with normal serum creatinine, Bun
and GfR (n = 21, group 1) and those with elevated
serum creatinine/Bun and decreased GfR (n = 15,
group 2). 
Mean age of both groups was similar without sig-
nificant difference (group 1: 60.2 ﾱ 9.6 years, group
2:63.4 ﾱ 6.1. years). all relevant clinical and laboratory
data are given in table 1.
In  both  groups  similar  values  were  measured  for
kidney length (group 1: right 10.3/left 10.9 cm; group
2:  right  10.1/left  10.5  cm)  and  parenchyma  width
(group 1: right 1.7/left 1.6 cm; group 2: right 1.5/left
1.6 cm) (table 2). 
only  four    group  1  patients  (24%),  but  nine  of
group 2 patients (60%) revealed hyperechogenicity of
renal parenchyma as hint to an interstitial nephropa-
thy. this difference was statistical significant (p<0.01). 
Mean renal RI indices were 0.67 ﾱ 0.06 (right) and
0.69 ﾱ 0.06 (left) in group 1 patients and 0.71 ﾱ 0.08
(right) and 0.71 ﾱ 0.07 (left) in group 2 patients. the
slight  differences  were  without  statistical  difference
(right p = 0.06, left p = 0.15) (table 2).
DIscussIon
Measurement  of  the  intrarenal  resistance  index  (RI)
has been widely applied in the evaluation of renovas-
cular changes.  It is a suitable method for the determi-
nation of vasoconstrictive effects in the kidney.  Most
investigators define a value lower than 0.7 as normal in
the  adult  population.  Important  to  know  that  the
height  of  RI  depends  on  interobserver-variabilities
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Fig  1.  sonographical  measurement  of  the  length  (10.6  cm)
and the parenchymal width (1.9 cm) of the right kidney in a
patient with multiple myeloma.
Fig. 2. Measurement of intrarenal resistance index (RI) on a
segmental  arteria.  at  least  three  waveforms  following  each
other were documented. RI is determined with a value of 0.68.
Table 1. clinical and laboratory data of 36 multiple myeloma
patients with normal (group 1) and impaired (group 2) renal
function.
Group 1 Group 2
number of patients (n) 21 15
Mean age (years) 60.2 ﾱ 9.6 63.4 ﾱ 6.1
serum creatinine (mg/dl) 0.85 ﾱ 0.2 3.1 ﾱ 1.1
Bun (mg/dl) 13.5 ﾱ 3.4 41 ﾱ 23
GfR (ml/min) 101 ﾱ25 35 ﾱ 21
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tive study  we determined values in a range between
0.59 – 0.63 upon 78 healthy subjects and revealed that
RI  increases  with  age,  about    0.001  per  year  [13],
which is in accordance to others [14]. 
Renal vasoconstriction occurs under an activated re-
nine-angiotensine-aldosterone system, for example in
hepatic diseases like liver cirrhosis patients [15]. Re-
cently, we revealed that  renal RI measurement  in liver
cirrhosis correlates with the degree of vasoactive dys-
regulation and is an early sign of renal impairment as
hints to a risk for hepatorenal syndrome.  liver cirrho-
sis  patients with ascites (0.74) revealed significantly
higher RI values than patients without ascites (0.67)
and patients with elevated creatinine (0.77) had higher
values  than  those  patients  with  normal  creatinine
(0.69) [16].
In multiple myeloma patients there was no signifi-
cant difference between RI of those with elevated cre-
atinine (0.71) and those with normal creatinine (0.68).
obviously, the structural alterations of the kidneys do
not lead to relevant vasoconstrictive effects.  
In multiple myeloma patients kidneys are most fre-
quently damaged directly by light chain components of
the  monoclonal  immunoglobulin  causing  proximal
tubular  deletions  and  consecutive  interstitial  cast
nephropathy  [17].  Beside  this,  amyloidosis  and  light
chain deposition disease are other causes of chronic
renal  impairment  in  multiple  myeloma  patients.  as
there  is  usually  no  therapeutic  consequence  invasive
renal biopsy to determine the type of renal damage is
not routinely performed and not recommended. also
in our patients, histology of renal disease was not ob-
tained. Renal failure is a complication of high tumor
burden  and  is  a  risk  factor  for  a  lower  response  to
treatment and a poor prognosis [7, 18, 19]. Hypercal-
cemia, dehydration, infection, hyperuricemia and the
use of nephrotoxic drugs also contributes to its aggra-
vation [20] so that up to 3% of the patients require at
least  intermittend  dialysis  [3-8].  after  effective
chemotherapy approximately 25% of the patients re-
cover normal kidney function [18]. the renal recovery
correlates with the reduction of free light chains by
plasma exchange [21].
this has also been shown for new therapeutic ap-
proaches in recurrent and refractory multiple myelo-
ma. In these severe cases, Bortezomib for example, a
selective and reversible proteasome inhibitor, provides
clinical benefit of kidney function [22].
so  far,  no  Doppler  sonographical  data  exist
whether vascular dysregulation occurs in myeloma kid-
neys and if these hypothesized effects would show re-
versibility  under  effective  therapeutic  regimen.    our
results reveal only a non-significant elevation of renal
RI in multiple myeloma patients compared to RI in
healthy controls. 
analogous studies have already been performed for
systemic lupus nephritis,  another kind of interstitial
nephropathy [23, 24]. Herein, the data were controver-
sial so that it remains unclear whether renal RI is ele-
vated or not in these patients.
In  contrast,  significantly  more  myeloma  patients
with elevated creatinine and Bun as well as reduced
GfR values reveal  hyperechogenic kidney parenchy-
ma than those with normal renal function, which is a
morphological sign for interstitial nephropathy.
In summary, in spite of the limited number of pa-
tients measurement of renal RI does not  give  hints to
a relevant vasoconstriction and is therefore no relevant
parameter  for  the  diagnosis  of  cast  nephropathy  of
multiple myeloma patients. Routinely performed ultra-
sound examination should be more focussed on the
qualification of parenchymal echogenicity. 
Acknowledgement: this study was supported by grants of the
friedrich-Baur-stiftung (Munich).
REfEREncEs
1. Vivaldi P., comotti c., Pedrazolli M. the kidney in multi-
ple myeloma. the physiopathological and clinical aspects.
Recenti Prog Med 1944;85(2):123-33.
2. clark aD, shetty a, soutar R. Renal failure and multiple
myeloma: pathogenesis and treatment of renal failure and
management of underlying myeloma. Blood Rev 1999;13:
79-90
3. alexanian R., Barlogie B., Dixon D. Renal failure in mul-
tiple myeloma. Pathogenesis and prognostic implications.
arch Intern Med 1990;150:1693-1695
4. Johnson wJ., Kyle Ra., Pineda aa., o’ Brien Pc., Holley
KE. treatment of renal failure associated with multiple
myeloma. Plamapheresis, hemodialysis, and chemothera-
py. arch Intern Med 1990;150:863-869
5. torra R., Blade J., cases a., lopez-Pedret J., Montserrat
E., Rozman c., Revert l. Patients with multiple myeloma
requiring long-term dialysis: presenting features, response
to therapy, and outcome in a series of 20 cases. Brit J
Haematol 1995;91:854-859
6. Montseny JJ., Kleinknecht D., Meyrier a., Vanhille P., si-
mon P., Pruna a., Eladari D. long-term outcome accord-
EuRoPEan JouRnal of MEDIcal REsEaRcH 212 May 18, 2010
Table 2. size of the kidneys, parenchymal width and resistance indices (RI) of multiple myeloma patients with normal (group 1)
and impaired (group 2) renal function.
Group 1 Group 2 p-value
length right kidney (cm) 10.5 ﾱ 0.9 10.1 ﾱ 1.6 n.s.
length left kidney (cm) 10.9 ﾱ 1.1 10.5 ﾱ 1.4 n.s.
Paren. width, right (cm) 1.7 ﾱ 0.2 1.5 ﾱ 0.3 n.s.
Paren. width, left (cm) 1.6 ﾱ 0.2 1.5 ﾱ 0.3 n.s.
Hyperechogenicity (n/%) 4 (24%) 9 (60%) <0.01
RI right kidney 0.67 ﾱ 0.06 0.71 ﾱ 0.08 0.06
RI left kidney 0.69 ﾱ 0.06 0.71 ﾱ 0.07 0.15
4. Schiemann_Umbruchvorlage  07.05.10  14:04  Seite 212EuRoPEan JouRnal of MEDIcal REsEaRcH May 18, 2010 213
ing to renal histological lesions in 118 patients with mon-
oclonal  gammopathies.  nephrol  Dial  transplant  1998;
13:1438-1445
7. Knudsen lM, Hjorth M, Hippe E. Renal failure in multi-
ple myeloma: reversibility and impact om the prognosis.
nordic myeloma study group.Eur J Haematol 2000; 65:
175-81.
8. Badros a., Barlogie B., siegel E., Roberts J., langmaid c.,
Zangari  M.,  Desikan  R.,  shaver  MJ.,  fassas  a.,  Mc-
connell s., Muwalla f., Barri y., anaissie E., Munshi n.,
tricot G. Results of autologous stem cell transplant in
multiple  myeloma  patients  with  renal  failure.  Brit  J
Haematol 2001;114:822-829
9. Dimopoulos Ma., Kastritis E., Rosinol l., Blad￩ J., lud-
wig H. Pathogenesis and treatment of renal failure in mul-
tiple myeloma. leukemia 2008;22(8):1485-93
10. Rivolta R, Maggi a, cazzaniga M, castagnone D, Panzeri
a, solenghi D, lorenzano E, Quatro di Palo f, salerno f:
Reduction  of  renal  cortical  blood  flow  assessed  by
Doppler in cirrhotic patients with refractory ascites. He-
patology 1998; 28: 1235-1240.
11. sacerdoti D, Gaiani s, Buonamico P, Merkel c, Zoli M,
Bolondi  l,  sabb￠  c.  Interobserver  and  interequipment
variability of hepatic, splenic and renal arterial Doppler
Resistance Indices in normal subjects and patients with
cirrhosis. Journal of Hepatology 1997; 27: 986-992
12. lin Zy., wang ly., yu Ml., Dai cy., chen sc., chuang
wl., Hsieh My., tsai Jf., chang wy. Influence of age
on intrarenal resistive index measurement in normal sub-
jects. abdom Imaging 2002;28:230-2
13. Kaiser c, G￶tzberger M, landauer n, Dieterle c, Held-
wein w, schiemann u:age dependency of intrarenal re-
sistance index (RI) in healthy adults and patients with fat-
ty liver disease. Eur J Med Res 2007; 12: 191-5.
14. Keogan Mt., Kliewer Ma., Hertzberg Bs., Delong DM.,
tulper RH., carroll Ba. Renal resistive indixes: variability
in Doppler us measurements in a healthy population. Ra-
diology 1996;199:165-169
15. Platt J, Ellis JH, Rubin JM, Merion RM, lucey MR. Renal
duplex Doppler ulrasonography: a noninvasive predictor
of kidney dysfunction and hepatorenal failure in liver dis-
ease. Hepatology 1994; 20: 362-369.
16. G￶tzberger  M.,  Kaiser  c.,  landauer  n.,  Dieterle  c.,
Heldwein w., schiemann u. Intrarenal resistance index
for the assessment of early renal function impairment in
patients with liver cirrhosis. Eur J Med Res 2008;13(8):
383-7
17. Bird  JM.,  fuge  R.,  sirohi  B.,  aperley  Jf.,  Hunter  a.,
snowden J., Mahendra P., Milligan D., Byrne J., little-
wood t., fegan c., McQuaker G., Pagliuca a., Johnson
P., Rahemtulla a., Morris c., Marks DI. the clinical out-
come and toxicity of high-dose chemotherapy and autolo-
gous stem cell transplantation in patients with myeloma
or amyloid and severe renal impairment: a British society
of  blood  and  marrow  transplantation  study.  Brit  J
Haematol 2006;134:385-390  
18. Blad￩ J., fernadez-llama P., Bosch f. et al. Renal failure
in multiple myeloma : presenting features and predictos
of outcome in 94 patients from a single institution. arch
Intern Med 1998;158:1889-1893
19. sakhuja V., Jha V.,  Varma s. et al. Renal involvement in
multiple  myeloma:  a  10-year  study.  Renal  fail  2000;22:
465-477
20. smith a., wisloff f., samson D. Guidelines on the diag-
nosis  and  management  of  multiple  myeloma.  British  J
Haematol 2006;132:410-451
21. leung  n.,  Gertz  Ma.,  Zeldenrust  sR.,  Rajkumar  sV.,
Dispenzieri a., fervenza fc., Kumar s., lacy MQ., lust
Ja.,  Greipp  PR.,  witzig  tE.,  Hayman  sR.,  Russell  sJ.,
Kyle Ra., winters Jl. Improvement of cast nephropathy
with plasma exchange depends on the diagnosis and on
reduction  of  serum  free  light  chains.  Kidney  Int
2008;73(11):1282-8 
22. Jagannath s., Barlogie B., Berenson JR., singhal s., alex-
anian R., srkalovic G., orlowski RZ., Richardson PG.,
anderson J., nix D., Esseltine Dl., anderson Kc. Borte-
zomib in recurrent and /or refractory multiple myeloma.
cancer 2005;103:1195-200 
23. ozbek ss., B￼y￼kberber s., tolunay o., Erden MI., ay-
tac sK., olmez u. Image directed color Doppler ultra-
sonography of kidney in systemic lupus nephritis. J clin
ultrasound 1995;23(1):17-20
24. Platt J, Rubin J, Ellis J. lupus nephritis: Predictive value
of conventional and Doppler ultrasound and comparison
with  serologic  and  biopsy  parameters.  Radiology  1997;
203: 82-86
25. aikimbaev Ks, canataroglu a, ozbek s, usal a. Renal
vascular resistance in progressive systemic sclerosis: Eval-
uation with duplex Doppler ultrasound. angiology 2001;
52: 697-701
Received: December 15, 2009 / Accepted: February 18, 2010
Address for correspondence:
PD Dr. med. u. schiemann
Klinik f￼r allgemeine Innere Medizin/ notfallzentrum
Inselspital Bern (universit￤tsspital)
freiburgstrasse
3010 Bern
switzerland
tel.: ++41-31-632 2111
fax: ++41-31-632 4814
E-mail:  uwe.schiemann@insel.ch
4. Schiemann_Umbruchvorlage  07.05.10  14:04  Seite 213